Equity (Tables)

12 Months Ended

Dec. 31, 2021

Equity

Schedule of status of the restricted stock grants issued under the Equity Plan

	The Year Ended December 31,
	2021			2020
		Weighted			Weighted
		Average Grant			Average
		Date Fair			Grant Date
	Number of	Value Per		Number of	Fair Value
Restricted Stock Grants	Shares	Share		Shares	Per Share
Outstanding at beginning of period	224,002	$	0.36	318,003	$	0.30
Granted during the period	335,000		0.67	300,000		0.42
Restrictions lifted during the period	(265,668)		0.47	(394,001)		0.36
Forfeited during the period	—		—	—		—
Outstanding at end of period	293,334	$	0.61	224,002	$	0.36

Schedule of status of the stock option grants issued under the Equity Plan

	The Year Ended December 31,
	2021			2020
		Weighted			Weighted
		Average Grant			Average
		Date Fair			Grant Date
	Number of	Value Per		Number of	Fair Value
Restricted Stock Units	Shares	Share		Shares	Per Share
Outstanding at December 31, 2020	3,610,038	$	0.70	2,830,038	$	0.78
Granted during the period	400,000		0.60	780,000		0.40
Restrictions lifted during the period	—		—	—		—
Forfeited during the period	—		—	—		—
Outstanding December 31, 2021	4,010,038	$	0.69	3,610,038	$	0.70

Summary of the status of the Company's common stock warrants

		Weighted
	Number of	Average Exercise
	Underlying	Price Per
Common Stock Warrants	Shares	Share
Outstanding at December 31, 2019	14,653,846	$	0.39
Granted during the period:
April 2020 Series A warrants	7,500,000		0.30
April 2020 Series B warrants	3,750,000		0.30
Exercised during period
April 2020 Series A warrants	(5,000,000)		0.30
April 2020 Series B warrants	(3,500,000)		0.30
Outstanding at December 31, 2020	17,403,846		0.38
Exercised during period
July 2019 Series A warrants	(200,000)		0.35
July 2019 Series B warrants	(1,500,000)		0.35
April 2020 Series A warrants	(1,400,000)		0.30
Expired during period
May 2016 warrants	(1,500,000)		0.75
Outstanding December 31, 2021	12,803,846	$	0.34